fashion -WSS

fashion

author：leisure time 2025-09-28 04:58:56 - browse：95261

Daphne Koller -- biotech coverage from STAT — Daphne Koller, early biotech AI entrant Insitro's founder, CEO and board member. Courtesy Jerrick Mitra/Insitro

New artificial intelligence technologies made headlines last year for their ability to do everything from generating fake musical duets to understanding how proteins fold. But in biotech, one of the most well-funded AI players has been quiet.

Insitro, a South San Francisco firm, was founded in 2018 by Daphne Koller, who had previously been a Stanford professor, a 2004 MacArthur “genius” grant recipient, and the co-founder and co-CEO of the online course company Coursera. It raised more than $643 million in venture capital, according to PitchBook, from investors including T. Rowe Price, ARCH Venture Partners, and Casdin Capital. The company now has more than 260 employees spread out over 107,000 square feet of laboratory and office space.

But what exactly is Koller building?

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
Next article： Amylyx ALS drug fails large clinical trial

leisure time

WSS

UnitedHealth quietly bought dozens of outpatient centers

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

What to do when lifesaving products contribute to climate change

Just how do doctors, lawmakers, and the public define abortion?

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

Change Healthcare payments predicted restored March 15

Wikipedia

fashion

entertainment

Activists slam private health insurers over coverage restrictions

30 years of 'Listening to Prozac'

Trump demands the U.S. pay no more for drugs than other countries … again

ReNAgade cuts staff seven months after raising $300 million

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

NEJM study link tiny plastics in blood vessels to heart problems

DIEP, the 'gold standard' of breast reconstruction, is under threat

How to bring more disabled researchers into academia

Dobbs anniversary: the lost opportunity of abortion as health care

CDC director unscathed in first congressional testimony

knowledge

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Former medical device CEO who sold dummy, plastic parts convicted of fraud

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

What to do when lifesaving products contribute to climate change

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

hotspot

focus

leisure time

entertainment